Trial · NCT00972504
Results by group64
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 64
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Weighted Mean TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | Placebo | 4.9 | 95% Confidence Interval 4.4 to 5.4 | Score on a scale | |
| Weighted Mean TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | GSK1004723 1000 µg Once Daily | 4.2 | 95% Confidence Interval 3.7 to 4.8 | Score on a scale | |
| Weighted Mean TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | GSK835726 10 mg Once Daily | 3.6 | 95% Confidence Interval 3.1 to 4.1 | Score on a scale | |
| Weighted Mean TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | Cetirizine 10 mg Once Daily | 3.5 | 95% Confidence Interval 3.0 to 4.1 | Score on a scale | |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | Placebo | Nasal Blockage | 1.5 | 95% Confidence Interval 1.3 to 1.7 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | GSK1004723 1000 µg Once Daily | Nasal Blockage | 1.7 | 95% Confidence Interval 1.5 to 1.8 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | GSK835726 10 mg Once Daily | Nasal Blockage | 1.3 | 95% Confidence Interval 1.1 to 1.4 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | Cetirizine 10 mg Once Daily | Nasal Blockage | 1.3 | 95% Confidence Interval 1.1 to 1.4 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | Placebo | Rhinorrhoea | 1.5 | 95% Confidence Interval 1.3 to 1.7 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | GSK1004723 1000 µg Once Daily | Rhinorrhoea | 1.3 | 95% Confidence Interval 1.1 to 1.4 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | GSK835726 10 mg Once Daily | Rhinorrhoea | 1.1 | 95% Confidence Interval 0.9 to 1.3 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | Cetirizine 10 mg Once Daily | Rhinorrhoea | 1.0 | 95% Confidence Interval 0.9 to 1.2 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | Placebo | Nasal Itching | 1.1 | 95% Confidence Interval 0.9 to 1.3 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | GSK1004723 1000 µg Once Daily | Nasal Itching | 0.9 | 95% Confidence Interval 0.7 to 1.0 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | GSK835726 10 mg Once Daily | Nasal Itching | 0.8 | 95% Confidence Interval 0.6 to 1.0 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | Cetirizine 10 mg Once Daily | Nasal Itching | 0.8 | 95% Confidence Interval 0.6 to 1.0 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | Placebo | Sneezing | 0.8 | 95% Confidence Interval 0.7 to 0.9 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | GSK1004723 1000 µg Once Daily | Sneezing | 0.4 | 95% Confidence Interval 0.3 to 0.6 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | GSK835726 10 mg Once Daily | Sneezing | 0.5 | 95% Confidence Interval 0.4 to 0.6 | Score on a scale |
| Weighted Mean of the Individual Components of TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 | Cetirizine 10 mg Once Daily | Sneezing | 0.5 | 95% Confidence Interval 0.3 to 0.6 | Score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00972504/results